Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model)
- PMID: 11145237
- DOI: 10.1023/a:1026455822595
Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model)
Abstract
Purpose: The aims of this study were (i) to elucidate the transport mechanisms involved in drug release from hydrophilic matrices; and (ii) to develop an improved mathematical model allowing quantitative predictions of the resulting release kinetics.
Methods: Our previously presented model has been substantially modified, by adding: (i) inhomogeneous swelling; (ii) poorly water-soluble drugs; and (iii) high initial drug loadings. The validity of the improved model has been tested experimentally using hydroxypropyl methylcellulose (HPMC)-matrices, containing either a poorly or a freely water-soluble drug (theophylline or chlorpheniramine maleate) at various initial loadings in phosphate buffer pH 7.4 and 0.1 N HCl, respectively.
Results: By overcoming the assumption of homogeneous swelling we show that the agreement between theory and experiment could be significantly improved. Among others, the model could describe quantitatively even the very complex effect on the resulting relative release rates (first slowing down, then accelerating drug release) observed when increasing the initial loading of poorly water-soluble drugs.
Conclusions: The practical benefit of this work is an improved design model that can be used to predict accurately the required composition and dimensions of drug-loaded hydrophilic matrices in order to achieve desired release profiles, thus facilitating the development of new pharmaceutical products.
Similar articles
-
HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.Pharm Res. 1999 Nov;16(11):1748-56. doi: 10.1023/a:1018914301328. Pharm Res. 1999. PMID: 10571282
-
Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.Int J Pharm. 2000 May 25;201(2):151-64. doi: 10.1016/s0378-5173(00)00390-2. Int J Pharm. 2000. PMID: 10878322
-
Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer.J Pharm Sci. 1995 Dec;84(12):1455-63. doi: 10.1002/jps.2600841213. J Pharm Sci. 1995. PMID: 8748329
-
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).Adv Drug Deliv Rev. 2001 Jun 11;48(2-3):139-57. doi: 10.1016/s0169-409x(01)00112-0. Adv Drug Deliv Rev. 2001. PMID: 11369079 Review.
-
Modeling of drug release from polymeric delivery systems--a review.Crit Rev Ther Drug Carrier Syst. 2004;21(5):345-86. doi: 10.1615/critrevtherdrugcarriersyst.v21.i5.10. Crit Rev Ther Drug Carrier Syst. 2004. PMID: 15717734 Review.
Cited by
-
Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.Drug Deliv Transl Res. 2019 Feb;9(1):162-177. doi: 10.1007/s13346-018-00592-0. Drug Deliv Transl Res. 2019. PMID: 30341764
-
From Heuristic to Mathematical Modeling of Drugs Dissolution Profiles: Application of Artificial Neural Networks and Genetic Programming.Comput Math Methods Med. 2015;2015:863874. doi: 10.1155/2015/863874. Epub 2015 May 26. Comput Math Methods Med. 2015. PMID: 26101544 Free PMC article.
-
The role of oral controlled release matrix tablets in drug delivery systems.Bioimpacts. 2012;2(4):175-87. doi: 10.5681/bi.2012.027. Epub 2012 Nov 4. Bioimpacts. 2012. PMID: 23678458 Free PMC article.
-
A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function.Pharm Res. 2003 Jul;20(7):988-95. doi: 10.1023/a:1024497920145. Pharm Res. 2003. PMID: 12880283
-
Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.AAPS PharmSciTech. 2015 Apr;16(2):398-406. doi: 10.1208/s12249-014-0234-4. Epub 2014 Oct 18. AAPS PharmSciTech. 2015. PMID: 25331194 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources